Reply to Drug industry takes great care to be responsible healthcare partner BMJ2011;343doi: http://dx.doi.org/10.1136/bmj.d6695 (Published 26 October 2011)
Published as a letter in the BMJ, October 2011: http://www.bmj.com/content/343/bmj.d7375?tab=related
I have in front of me an invitation to a “Changing Faces conference – examining advances in diagnosis and treatment of bipolar I disorder.” This conference is sponsored by here Lundbeck, is certified for continuous professional development but is a symposium to promote asenapine (Syncrest). I would suggest this much is transparent.
I support the pharmaceutical industry, research, innovation and development. But I do not support the mixing of marketing with education. I never will.
Forth Valley NHS has a voluntary system for disclosing “hospitality.” This register has not so far been accessible. Surely we have opacity rather than transparency?’ 
Competing interests: None declared.
 Whitehead, S. Drug Industry takes great care to be a responsible healthcare partner. BMJ 2011;343d6695 (26 October